PJORX
Price
$16.75
Change
+$0.08 (+0.48%)
Updated
Jul 25 closing price
Net Assets
278.33M
VVIAX
Price
$70.44
Change
+$0.29 (+0.41%)
Updated
Jul 25 closing price
Net Assets
195.18B
Interact to see
Advertisement

PJORX vs VVIAX

Header iconPJORX vs VVIAX Comparison
Open Charts PJORX vs VVIAXBanner chart's image
PGIM Jennison Focused Value R
Price$16.75
Change+$0.08 (+0.48%)
VolumeN/A
Net Assets278.33M
Vanguard Value Index Adm
Price$70.44
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets195.18B
PJORX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PJORX vs. VVIAX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PJORX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 195B vs. PJORX (278M). VVIAX pays higher dividends than PJORX: VVIAX (2.18) vs PJORX (0.85). PJORX was incepted earlier than VVIAX: PJORX (21 years) vs VVIAX (25 years). PJORX (4.11) is less costly to investors than VVIAX (0.05). PJORX is a more actively managed with annual turnover of: 42.00 vs. VVIAX (9.00). PJORX has a lower initial minimum investment than VVIAX: PJORX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 9.30 vs. PJORX (3.79). VVIAX return over 5 years is better than : 74.15 vs. PJORX (46.84).
PJORXVVIAXPJORX / VVIAX
Total Expense Ratio1.530.053,060%
Annual Report Gross Expense Ratio4.110.058,220%
Fund Existence21 years25 years-
Gain YTD6.5186.274104%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets278M195B0%
Annual Yield % from dividends0.852.1839%
Returns for 1 year3.799.3041%
Returns for 3 years26.9333.7780%
Returns for 5 years46.8474.1563%
Returns for 10 years-6.04115.37-5%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVO4.260.21
+5.19%
Evotec SE
MAPS0.970.02
+2.12%
WM Technology
EG336.860.99
+0.29%
Everest Group Ltd
ARTL13.73-0.03
-0.22%
Artelo Biosciences Inc
BCAX11.75-0.18
-1.51%
Bicara Therapeutics Inc.